Correction: Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. Coli and Klebsiella in Africa

Correction to Antimicrobial Resistance & Infection Control (2023) 12:29

10.1186/s13756-023-01220-4

The original article contains two errors that the authors wish to note corrections for:

1. In Table 2, the four cells in the ‘All reporting nations’ each display incorrect values, and should each instead be displayed as in the amended Table 1 ahead.

2. In Additional File 1, a search term was inadvertently repeated when the intent was to include a special character, and there is an additional inadvertent repetition of a term. The corrected Additional File 1 can be viewed via this Correction article.

Table 2.

Available reports on E. coli and Klebsiella carbapenem and polymyxin susceptibility, resistance, and related genes

Nation	All reports on named species (reports identifying resistance or determinants related to resistance)
	Carbapenem		Polymyxin (colistin and polymyxin B)
	E. coli	Klebsiella	E. coli	Klebsiella	References
Algeria	33 (12)	37 (18)	17 (4)	22 (3)	[48–97]
Angola	2 (2)	2 (2)	1 (0)	1 (0)	[98,99]
Benin	6 (4)	2 (1)	2 (0)	2 (0)	[100–105]
Botswana	1 (0)	1 (0)	0	0	[106]
Burkina Faso	12 (4)	13 (0)	3 (2)	1 (0)	[25,107–121]
Cameroon	11 (3)	7 (3)	3 (2)	1 (0)	[116,122–133]
Cape Verde	1 (0)	0	0	0	[116]
Central African Republic	2 (0)	3 (0)	0	0	[25,134,135]
Chad	8 (4)	4 (1)	1 (0)	0	[57,116,136–141]
Congo	2 (2)	1 (1)	1 (0)	0	[142,143]
Côte d’Ivoire	4 (1)	5 (1)	1 (1)	0	[144–150]
Democratic Republic of the Congo	3 (0)	2 (1)	0	0	[151–153]
Djibouti	2 (1)	0	1 (0)	0	[57,154]
Egypt	106 (66)	125 (98)	28 (14)	34 (15)	[1,25–27,57,78,116,155–293]
Equatorial Guinea	1 (0)	1 (1)	0	0	[294]
Eritrea	1 (0)	0	1 (0)	0	[295]
Ethiopia	19 (10)	27 (17)	4 (4)	6 (4)	[1,112,296–316]
Gabon	4 (0)	5 (1)	0	0	[317–321]
Gambia	1 (1)	1 (1)	0	0	[322]
Ghana	15 (5)	15 (8)	1 (1)	1 (1)	[116,323–337]
Guinea	1 (0)	0	0	0	[116]
Guinea-Bissau	1 (0)	1 (0)	0	0	[338]
Kenya	26 (11)	25 (21)	2 (1)	2 (0)	[116,168,268,282,339–362]
Libya	17 (10)	22 (20)	3 (0)	8 (4)	[57,78,363–385]
Madagascar	14 (3)	12 (6)	0	0	[1,26,27,112,116,168,386–395]
Malawi	4 (3)	7 (5)	1 (0)	2 (0)	[26,27,396–398]
Mali	4 (3)	2 (1)	1 (0)	0	[1,57,399,400]
Mauritania	1 (1)	1 (0)	1 (1)	1 (1)	[401]
Mauritius	4 (2)	6 (5)	1 (0)	2 (1)	[25,57,168,183,402–404]
Morocco	24 (13)	39 (24)	6 (2)	10 (2)	[25,57,78,116,183,268,282,405–433]
Mozambique	6 (1)	4 (0)	1 (0)	0	[1,116,427,434–438]
Namibia	1 (0)	5 (1)	0	0	[25,183,439]
Niger	5 (2)	2 (0)	1 (1)	1 (1)	[57,440–443]
Nigeria	82 (53)	80 (46)	32 (23)	28 (15)	[1,27,116,444–561]
Rwanda	7 (3)	6 (2)	1 (1)	1 (1)	[562–568]
Sao Tome and Principe	1 (1)	1 (1)	1 (1)	0	[569]
Senegal	10 (2)	11 (6)	1 (1)	3 (1)	[56,78,112,116,145,570–581]
Sierra Leone	5 (3)	4 (3)	0	0	[116,582,583]
Somalia	1 (0)	0	1 (0)	0	[295]
South Africa	69 (25)	109 (82)	18 (8)	20 (10)	[1,25,78,168,183,268,282,519,584–663]
South Sudan	1 (0)	0	0	0	[664]
Sudan	12 (7)	10 (5)	1 (1)	1 (1)	[1,27,112,116,665–673]
Tanzania	29 (6)	26 (7)	2 (1)	2 (1)	[56,112,116,168,674–700]
Togo	6 (4)	4 (3)	3 (1)	3 (1)	[116,701–706]
Tunisia	34 (14)	70 (43)	15 (4)	29 (13)	[1,26,27,78,168,183,268,282,707–774]
Uganda	17 (10)	16 (11)	2 (1)	2 (1)	[1,26,27,168,775–788]
Zambia	3 (1)	4 (4)	0	0	[26,27,789,790]
Zimbabwe	3 (1)	1 (1)	0	0	[116,791,792]
All reporting nations	622 (294)	719 (451)	158 (75)	183 (76)

Reports on carbapenem or polymyxin susceptibility were not identified from the following searched nations: Burundi, Comoros, Lesotho, Liberia, Seychelles and Swaziland

Electronic supplementary material

Below is the link to the electronic supplementary material.